Clinical Trials Logo

Hallux Rigidus clinical trials

View clinical trials related to Hallux Rigidus.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04103814 Terminated - Hallux Valgus Clinical Trials

Effect of Topical CBD Cream for Degenerative Hallux Disorders

Start date: October 20, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

Hallux rigidus and hallux valgus are chronic forefoot conditions associated with pain, inflammation and functional impairment. Topical cannabidiol (CBD) cream has been shown to decrease inflammation, swelling, and pain response in arthritis models with minimal side effects, although the intervention has never been studied in hallux valgus or hallux rigidus. The purpose of this study is to determine if topical CBD cream is an effective treatment for pain secondary to hallux rigidus and hallux valgus.

NCT ID: NCT03935880 Terminated - Hallux Rigidus Clinical Trials

Surgical Treatment for Great Toe Arthritis

Start date: April 15, 2019
Phase: N/A
Study type: Interventional

After potential subjects determine that they would like surgical treatment of their great toe arthritis, study staff will approach them about the study. If subject decides to participate, they will be asked to fill out an informed consent. After the informed consent has been signed, study staff will collect subject demographics and medical/surgical history. The subject will be randomized into one of two surgical treatment options: cheilectomy or Cartiva hemiarthroplasty. The randomization ratio will be 1:1 and to ensure this randomization ratio, each randomization block will have 4-6 patients. After the surgery, the subject will have follow up visits at 2 weeks, 6 weeks, 3 months, 1 year, and 2 years post surgery. At these follow up visits, subjects will have a physical exam conducted, have their medical imaging reviewed, and fill out a data collection form which will include questionnaires and adverse event forms (when applicable). All of the above will apply to the 2 week visit, except for the administration of questionnaires/surveys. Additionally, subjects will have incision check, suture removal, and a physical completed during this visit.All study procedures for this study are considered standard of care. Patients would have these completed regardless of participation in the study.

NCT ID: NCT02499575 Terminated - Hallux Rigidus Clinical Trials

Pericapsular Exparel for Pain Relief in Bunionectomy and Related Procedures

Start date: July 2015
Phase: N/A
Study type: Interventional

Exparel is an FDA-approved local anesthetic (bupivacaine), in a long-release formulation. In this study the investigators plan to determine the ability of Exparel to control post-operative pain in common first metatarsophalangeal (MTP) joint procedures (bunion surgery, 1st MTP fusion, and cheilectomy).

NCT ID: NCT01589679 Terminated - Hallux Limitus Clinical Trials

Contracture Reduction Following Bunionectomy: a Longitudinal, Controlled Trial

Bunionectomy
Start date: April 2012
Phase: N/A
Study type: Interventional

To determine the efficacy of Metatarsal Dynasplint Sytem (MTP) in reducing contracture of hallux limitus secondary to Bunionectomy, in a longitudinal, controlled trial.